NO972558L - Sett for osteoporose-behandlingssyklus - Google Patents

Sett for osteoporose-behandlingssyklus

Info

Publication number
NO972558L
NO972558L NO972558A NO972558A NO972558L NO 972558 L NO972558 L NO 972558L NO 972558 A NO972558 A NO 972558A NO 972558 A NO972558 A NO 972558A NO 972558 L NO972558 L NO 972558L
Authority
NO
Norway
Prior art keywords
treatment cycle
osteoporosis treatment
osteoporosis
solvate
kit
Prior art date
Application number
NO972558A
Other languages
English (en)
Norwegian (no)
Other versions
NO972558D0 (no
Inventor
Martine Gazard
Olivier Gros
Jacques Girard
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of NO972558D0 publication Critical patent/NO972558D0/no
Publication of NO972558L publication Critical patent/NO972558L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
NO972558A 1994-12-06 1997-06-05 Sett for osteoporose-behandlingssyklus NO972558L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9414630A FR2727629A1 (fr) 1994-12-06 1994-12-06 Trousse pour cycle de traitement de l'osteoporose
PCT/FR1995/001596 WO1996017616A1 (fr) 1994-12-06 1995-12-05 Trousse pour cycle de traitement de l'osteoporose

Publications (2)

Publication Number Publication Date
NO972558D0 NO972558D0 (no) 1997-06-05
NO972558L true NO972558L (no) 1997-08-05

Family

ID=9469504

Family Applications (1)

Application Number Title Priority Date Filing Date
NO972558A NO972558L (no) 1994-12-06 1997-06-05 Sett for osteoporose-behandlingssyklus

Country Status (20)

Country Link
EP (1) EP0797444A1 (pt)
JP (1) JPH10509729A (pt)
KR (1) KR980700083A (pt)
CN (1) CN1168634A (pt)
AR (1) AR002946A1 (pt)
AU (1) AU4307396A (pt)
BR (1) BR9509961A (pt)
CA (1) CA2207028A1 (pt)
CZ (1) CZ175397A3 (pt)
FI (1) FI972383A0 (pt)
FR (1) FR2727629A1 (pt)
HU (1) HUT77382A (pt)
IL (1) IL116168A0 (pt)
MA (1) MA23737A1 (pt)
NO (1) NO972558L (pt)
PL (1) PL320564A1 (pt)
SK (1) SK68597A3 (pt)
TR (1) TR199501530A1 (pt)
WO (1) WO1996017616A1 (pt)
ZA (1) ZA9510184B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5994329A (en) 1997-07-22 1999-11-30 Merck & Co., Inc. Method for inhibiting bone resorption
US6432932B1 (en) 1997-07-22 2002-08-13 Merck & Co., Inc. Method for inhibiting bone resorption
CN100551377C (zh) 2002-05-10 2009-10-21 弗·哈夫曼-拉罗切有限公司 用于治疗和预防骨质疏松症的二膦酸
PL212072B1 (pl) * 2002-12-20 2012-08-31 Hoffmann La Roche Tabletka zawierająca jako substancję czynną do 250 mg kwasu ibandronowego oraz sposób jej wytwarzania

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0162510B1 (en) * 1984-04-30 1991-08-28 THE PROCTER & GAMBLE COMPANY Kit for use in the treatment of osteoporosis
US4761406A (en) * 1985-06-06 1988-08-02 The Procter & Gamble Company Regimen for treating osteoporosis
ES2111163T3 (es) * 1992-06-30 1998-03-01 Procter & Gamble Pharma Uso de fosfonatos para el tratamiento de la osteoporosis.
FR2694558B1 (fr) * 1992-08-05 1994-10-28 Sanofi Elf Monohydrate du sel disodique de l'acide 4-chlorophénylthiométhylène bisphosphonique, sa préparation, les compositions pharmaceutiques en contenant.

Also Published As

Publication number Publication date
JPH10509729A (ja) 1998-09-22
PL320564A1 (en) 1997-10-13
MA23737A1 (fr) 1996-07-01
SK68597A3 (en) 1997-11-05
MX9704105A (es) 1997-09-30
EP0797444A1 (fr) 1997-10-01
CA2207028A1 (en) 1996-06-13
AR002946A1 (es) 1998-05-27
CZ175397A3 (en) 1997-10-15
FR2727629A1 (fr) 1996-06-07
CN1168634A (zh) 1997-12-24
NO972558D0 (no) 1997-06-05
FR2727629B1 (pt) 1997-02-28
TR199501530A1 (tr) 1996-10-21
FI972383A (fi) 1997-06-05
WO1996017616A1 (fr) 1996-06-13
BR9509961A (pt) 1997-11-25
FI972383A0 (fi) 1997-06-05
AU4307396A (en) 1996-06-26
HUT77382A (hu) 1998-04-28
KR980700083A (ko) 1998-03-30
ZA9510184B (en) 1996-06-11
IL116168A0 (en) 1996-01-31

Similar Documents

Publication Publication Date Title
HK56897A (en) Benzocyclobutyl-or indanyl-alkyl-amino-alkyl substituted 3-benzazepin-2-ones useful in the treatment of cardiovascular diseases
IS4083A (is) Samsetning lyfjaefna, aðferð til framleiðslu hennar, og notkunar sem lyfja
DE69721766D1 (de) Neue arzneiformulierung
DE3463442D1 (en) Arched bridge staple
NO307408B1 (no) Aminosukker og glykosaminglykansammensetning for behandling og reparasjon av bindevev
EP0209689A3 (en) Use of tetrahydrobiopterins in the treatment of infantile autism
NO20061455L (no) 2,6 dioksopiperidin samt farmasoytiske preparater som inneholder disse
DK0480934T3 (da) Lægemiddel, der indeholder ephedrin og koffein til behandling af overvægt
DK549189A (da) Galanthamin-analoge samt anvendelse af disse til fremstilling af laegemidler til behandling af alzheimer's syge
TW360544B (en) Analgestic and antiinflammatory fomentation pharmaceutical composition
DE69432984D1 (de) Therapeutische substituierte guanidine
ATE203907T1 (de) Dermatologische zubereitung zur behandlung von aktinischen keratosen
DE69316013D1 (de) Verwendung von phosphinate zur behandlung der osteoporose
DE59204543D1 (de) Chenodeoxycholsäure oder Ursodeoxycholsäure zur Behandlung von Erkrankungen der Atmungsorgane.
NO894222D0 (no) Fremgangsmaater for behandling av profylakse av pneumocytis carinii pneumoni og andre sykdommer og forbindelser og formuleringer til anvendelse i nevnte metoder.
NO972558L (no) Sett for osteoporose-behandlingssyklus
NO155375C (no) Naturlig vev egnet for implantering i en levende kropp samt fremgangsmaate til aa redusere forkalkningen av naturlig vev som finner sted etter implanteringen i en levende kropp
IS1910B (is) Notkun á fankínóni til meðhöndlunar á Alzheimers-sjúkdómi
NZ326345A (en) Composition containing diosgenin
DK325289A (da) Strontiumsalt, fremgangsmaade til fremstilling heraf samt farmaceutiske midler indeholdende saltet
ATE149840T1 (de) Behandlung von leberkrebs
DK0583281T3 (da) Modgift - immunsera
DK0546007T3 (da) Produkt, og anvendelse heraf til behandling af kataboliske tilstande, omfattende autentisk IGF-1 og hypokaloriske mængder af næringsmidler
NO308195B1 (no) Anvendelse av benzydamin til fremstilling av et legemiddel ved behandling av patologiske tilstander forÕrsaket av TNF
SE9303740D0 (sv) Farmaceutisk komposition